Streptozotocin Diabetic Rats
Streptozotocin Diabetic Rats - Related Videos
05:45
Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats
0 Views •
Cited by 10 •
2012
Here, we describe a rapid reliable and simple procedure to determine the lowest temperature at which rats or mice show nocifensive behavior, i.e. the thermal nociceptive threshold (TNT). This method applies a slowly increasing thermal stimulus allowing precise and reproducible estimation of TNTs with minimum, if any, stress to the animals.
10:27
An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models
0 Views •
Cited by 3 •
2017
This work presents the methodology of applying high intensity-focused ultrasound to block the action potentials of diabetic neuropathic nerves.
07:04
High-Intensity Focused Ultrasound for Blocking Nerve Action Potentials in a Diabetic Rat Model
0 Views •
2025
Source: Lee, Y. F., et al. An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models. J. Vis. Exp. (2017)This video demonstrates the use of high-intensity focused ultrasound (HIFU) to block action potentials from the sciatic nerve to the gastrocnemius muscle in a diabetic rat model. Upon delivering the HIFU beam to the nerve, a decrease in muscle signal confirms HIFU's potential as a non-invasive therapy for diabetic neuropathic pain relief.
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
0 Views •
Cited by 69 •
2013
Metabolic memory is the phenomenon by which diabetic complications persist and progress unimpeded even after euglycemia is achieved pharmaceutically. Here we describe a diabetes mellitus zebrafish model which is unique in that it allows for the examination of the mitotically transmissible epigenetic components of metabolic memory in vivo.
10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
0 Views •
Cited by 98 •
2007
Our protocol was developed to cleanly and easily deliver islets or cells under the kidney capsule of mice. Cells are concentrated into pellets in the final tubing used for transplanting the cells under the kidney capsule. The ease of this technique reduces stress to the cells and the mouse.
FAQs
Streptozotocin enters pancreatic β-cells through the GLUT2 glucose transporter, which helps explain why these insulin-producing cells are a major target. Inside the cells, it damages DNA and impairs their function, reducing insulin production. This cellular injury creates a biological basis for studying how impaired β-cell activity contributes to persistent abnormalities in glucose regulation.
Dose and administration conditions influence the severity of the diabetes-like state produced by streptozotocin. These variables affect the extent of β-cell damage, the resulting reduction in insulin production, and the degree of persistent hyperglycemia. Controlling them is therefore important when researchers need a consistent phenotype for comparing disease mechanisms, treatments, or tissue-level outcomes.
The central metabolic changes are reduced insulin production and persistent hyperglycemia. Together, they provide a controlled setting for examining insulin deficiency and broader metabolic dysfunction rather than studying glucose regulation only under normal conditions. Measurements and tissue analyses can consequently be interpreted in relation to an established diabetes-like state and its associated biological consequences.
Researchers establish the model by administering streptozotocin under defined experimental conditions and then considering the resulting diabetes-like phenotype. The selected dose and administration conditions must match the intended disease severity, because they influence β-cell damage and hyperglycemia. This controlled setup supports reproducible comparisons among untreated animals, diabetic animals, and groups receiving potential interventions.
This model is useful when a study requires persistent hyperglycemia, insulin deficiency, or metabolic dysfunction to be examined in a living organism. Researchers apply it to investigate diabetes pathophysiology, assess antidiabetic treatments, and evaluate potential therapeutic interventions. Its controlled and reproducible phenotype allows disease-related changes to be compared across experimental groups under defined conditions.
Studies may examine the kidney, nerves, blood vessels, and retina for changes associated with the diabetes-like state. These tissues broaden the model beyond pancreatic β-cell injury and glucose measurements, allowing researchers to investigate complications affecting different biological systems. Findings can help connect persistent hyperglycemia and metabolic dysfunction with tissue-specific outcomes relevant to diabetes research.